Not recruitingISRCTN25163383

Study to assess the safety and PK of novel CBD soft-gel capsule

This study is not recruiting in the United Kingdom. It focuses on Healthy volunteers. Intended indication is Clinical High Risk for Psychosis .; Mental and Behavioural Disorders.

Schizophrenia, Mental healthOtherFrom 18 Years to 55 Years

The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Clerkenwell Health
Sponsor type: Unknown or unclear
Study type: Other
Intervention type: Other / unclear
Study phase: Not clearly listed
Locations: United Kingdom
Age range: From 18 Years to 55 Years
Official registry ID: ISRCTN25163383
Official title: A phase 1 open-label study to assess the safety and PK of novel CBD soft-gel capsule

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Study ID: ISRCTN25163383. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Not recruiting

United Kingdom

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Clerkenwell Health.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me